Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Pulse Biosciences (PLSE).
Pulse Biosciences, Inc. has made significant board changes, electing Paul A. LaViolette as a director and appointing him to various leadership roles, including co-chairman and head of the new Strategic Advisory Committee. LaViolette, a seasoned healthcare executive with 40 years of experience, also received stock options as part of his non-employee director compensation. The company revised its compensation policy for non-employee directors, enhancing cash and equity compensation to align with their increased responsibilities and committee service.
For an in-depth examination of PLSE stock, go to TipRanks’ Stock Analysis page.
